- Home
- ETW vs NEO Comparison
ETW vs NEO Comparison
Compare ETW & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETW
- NEO
- Stock Information
- Founded
- ETW 2005
- NEO 2001
- Country
- ETW United States
- NEO United States
- Employees
- ETW N/A
- NEO N/A
- Industry
- ETW Investment Managers
- NEO Precision Instruments
- Sector
- ETW Finance
- NEO Health Care
- Exchange
- ETW Nasdaq
- NEO Nasdaq
- Market Cap
- ETW 904.6M
- NEO 965.2M
- IPO Year
- ETW N/A
- NEO 1999
- Fundamental
- Price
- ETW $8.42
- NEO $7.17
- Analyst Decision
- ETW
- NEO Buy
- Analyst Count
- ETW 0
- NEO 9
- Target Price
- ETW N/A
- NEO $13.31
- AVG Volume (30 Days)
- ETW 284.6K
- NEO 1.6M
- Earning Date
- ETW 01-01-0001
- NEO 04-29-2025
- Dividend Yield
- ETW 8.61%
- NEO N/A
- EPS Growth
- ETW N/A
- NEO N/A
- EPS
- ETW N/A
- NEO N/A
- Revenue
- ETW N/A
- NEO $672,361,000.00
- Revenue This Year
- ETW N/A
- NEO $13.95
- Revenue Next Year
- ETW N/A
- NEO $11.16
- P/E Ratio
- ETW N/A
- NEO N/A
- Revenue Growth
- ETW N/A
- NEO 10.10
- 52 Week Low
- ETW $6.96
- NEO $6.08
- 52 Week High
- ETW $8.49
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- ETW 60.96
- NEO 37.02
- Support Level
- ETW $8.32
- NEO $7.28
- Resistance Level
- ETW $8.41
- NEO $7.63
- Average True Range (ATR)
- ETW 0.07
- NEO 0.36
- MACD
- ETW 0.00
- NEO -0.00
- Stochastic Oscillator
- ETW 100.00
- NEO 9.26
About ETW Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.